Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or ...
From left, Dr. Vadim Guschin, Director of Mercy’s heated chemotherapy (HIPEC) program and a member of the Surgical Oncology Department, and Armando Sardi, M.D., Medical Director of The Institute for ...
Reply to: Blind Spots in REZILIENT-1: Does Post-Platinum Zipalertinib Address Needs in Epidermal Growth Factor Receptor ex20ins+ Non–Small Cell Lung Cancer? The article by Zwanenburg et al entitled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results